Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neurobiol Dis
2024 Aug 19;198:106537. doi: 10.1016/j.nbd.2024.106537.
Show Gene links
Show Anatomy links
AP2A2 mutation and defective endocytosis in a Malian family with hereditary spastic paraplegia.
Diarra S, Ghosh S, Cissé L, Coulibaly T, Yalcouyé A, Harmison G, Diallo S, Diallo SH, Coulibaly O, Schindler A, Cissé CAK, Maiga AB, Bamba S, Samassekou O, Khokha MK, Mis EK, Lakhani SA, Donovan FX, Jacobson S, Blackstone C, Guinto CO, Landouré G, Bonifacino JS, Fischbeck KH, Grunseich C.
???displayArticle.abstract???
Hereditary spastic paraplegia (HSP) comprises a large group of neurogenetic disorders characterized by progressive lower extremity spasticity. Neurological evaluation and genetic testing were completed in a Malian family with early-onset HSP. Three children with unaffected consanguineous parents presented with symptoms consistent with childhood-onset complicated HSP. Neurological evaluation found lower limb weakness, spasticity, dysarthria, seizures, and intellectual disability. Brain MRI showed corpus callosum thinning with cortical and spinal cord atrophy, and an EEG detected slow background in the index patient. Whole exome sequencing identified a homozygous missense variant in the adaptor protein (AP) complex 2 alpha-2 subunit (AP2A2) gene. Western blot analysis showed reduced levels of AP2A2 in patient-iPSC derived neuronal cells. Endocytosis of transferrin receptor (TfR) was decreased in patient-derived neurons. In addition, we observed increased axon initial segment length in patient-derived neurons. Xenopus tropicalis tadpoles with ap2a2 knockout showed cerebral edema and progressive seizures. Immunoprecipitation of the mutant human AP-2-appendage alpha-C construct showed defective binding to accessory proteins. We report AP2A2 as a novel genetic entity associated with HSP and provide functional data in patient-derived neuron cells and a frog model. These findings expand our understanding of the mechanism of HSP and improve the genetic diagnosis of this condition.
Abou Jamra,
Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature.
2011, Pubmed
Abou Jamra,
Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature.
2011,
Pubmed Ball,
Expression and localization of alpha-adaptin isoforms.
1995,
Pubmed Bauer,
Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47) .
2012,
Pubmed Bell,
A neuroprotective role for polyamines in a Xenopus tadpole model of epilepsy.
2011,
Pubmed
,
Xenbase Benmerah,
The tyrosine kinase substrate eps15 is constitutively associated with the plasma membrane adaptor AP-2.
1995,
Pubmed Bhattacharya,
CRISPR/Cas9: An inexpensive, efficient loss of function tool to screen human disease genes in Xenopus.
2015,
Pubmed
,
Xenbase Blackstone,
Hereditary spastic paraplegia.
2018,
Pubmed Boskovski,
The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia type and laterality.
2013,
Pubmed
,
Xenbase Boukhris,
Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity.
2009,
Pubmed Boukhris,
Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity.
2008,
Pubmed Bouslam,
Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28).
2005,
Pubmed Boutry,
Update on the Genetics of Spastic Paraplegias.
2019,
Pubmed Burguez,
Clinical and molecular characterization of hereditary spastic paraplegias: A next-generation sequencing panel approach.
2017,
Pubmed Choudhury,
High-depth African genomes inform human migration and health.
2020,
Pubmed Chrestian,
Clinical and genetic study of hereditary spastic paraplegia in Canada.
2017,
Pubmed Collins,
Molecular architecture and functional model of the endocytic AP2 complex.
2002,
Pubmed Coutinho,
Clinical heterogeneity of autosomal recessive spastic paraplegias: analysis of 106 patients in 46 families.
1999,
Pubmed Dell'Angelica,
Coatopathies: Genetic Disorders of Protein Coats.
2019,
Pubmed Dell'Angelica,
AP-4, a novel protein complex related to clathrin adaptors.
1999,
Pubmed Diarra,
Hereditary spastic paraplegia in Mali: epidemiological and clinical features.
2023,
Pubmed Do,
Hereditary Spastic Paraplegia in Koreans: Clinical Characteristics and Factors Influencing the Disease Severity.
2022,
Pubmed Erichsen,
Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study.
2009,
Pubmed Fernandopulle,
Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons.
2018,
Pubmed Guinto,
A novel mutation in KIF5A in a Malian family with spastic paraplegia and sensory loss.
2017,
Pubmed Hardies,
Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.
2015,
Pubmed Hedstrom,
Neurofascin assembles a specialized extracellular matrix at the axon initial segment.
2007,
Pubmed Helbig,
A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy.
2019,
Pubmed Helbig,
A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia.
2016,
Pubmed
,
Xenbase Hewapathirane,
In vivo imaging of seizure activity in a novel developmental seizure model.
2008,
Pubmed
,
Xenbase Hirst,
Characterization of a fourth adaptor-related protein complex.
1999,
Pubmed Hirst,
The fifth adaptor protein complex.
2011,
Pubmed Hirst,
Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15.
2013,
Pubmed Jackson,
A large-scale conformational change couples membrane recruitment to cargo binding in the AP2 clathrin adaptor complex.
2010,
Pubmed Kadlecova,
Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2.
2017,
Pubmed Koh,
JASPAC: Japan Spastic Paraplegia Research Consortium.
2018,
Pubmed Kole,
Action potential generation requires a high sodium channel density in the axon initial segment.
2008,
Pubmed Kole,
Axon initial segment Kv1 channels control axonal action potential waveform and synaptic efficacy.
2007,
Pubmed Kuba,
Presynaptic activity regulates Na(+) channel distribution at the axon initial segment.
2010,
Pubmed Kuba,
Redistribution of Kv1 and Kv7 enhances neuronal excitability during structural axon initial segment plasticity.
2015,
Pubmed Landouré,
Neurological Complications in Subjects With Sickle Cell Disease or Trait: Genetic Results From Mali.
2017,
Pubmed Landouré,
Hereditary spastic paraplegia type 35 in a family from Mali.
2019,
Pubmed Landouré,
A novel variant in the spatacsin gene causing SPG11 in a Malian family.
2020,
Pubmed Landouré,
Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.
2013,
Pubmed Lesca,
Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families.
2003,
Pubmed Mahungu,
A review of the genetic spectrum of hereditary spastic paraplegias, inherited neuropathies and spinal muscular atrophies in Africans.
2022,
Pubmed McMahon,
Molecular mechanism and physiological functions of clathrin-mediated endocytosis.
2011,
Pubmed McQueen,
An analysis of MyoD-dependent transcription using CRISPR/Cas9 gene targeting in Xenopus tropicalis embryos.
2017,
Pubmed
,
Xenbase Meilleur,
Genetic testing and counseling for hereditary neurological diseases in Mali.
2011,
Pubmed Meyyazhagan,
Hereditary Spastic Paraplegia: An Update.
2022,
Pubmed Moravec,
BRAG2/GEP100/IQSec1 interacts with clathrin and regulates α5β1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5).
2012,
Pubmed Moreno-De-Luca,
Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability.
2011,
Pubmed Murala,
Hereditary spastic paraplegia.
2021,
Pubmed Nagase,
Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
1998,
Pubmed Nesbit,
Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3.
2013,
Pubmed Ortega,
Hereditary spastic paraplegia: a clinical and epidemiological study of a Brazilian pediatric population.
2019,
Pubmed Owen,
Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation.
1998,
Pubmed Owen,
A structural explanation for the binding of multiple ligands by the alpha-adaptin appendage domain.
1999,
Pubmed Panza,
Hereditary spastic paraplegia: Genetic heterogeneity and common pathways.
2022,
Pubmed Pérez-Brangulí,
Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia.
2014,
Pubmed Ran,
Genome engineering using the CRISPR-Cas9 system.
2013,
Pubmed Richards,
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
2015,
Pubmed Robinson,
Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins).
1989,
Pubmed Robinson,
100-kD coated vesicle proteins: molecular heterogeneity and intracellular distribution studied with monoclonal antibodies.
1987,
Pubmed Ruano,
The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
2014,
Pubmed Sangaré,
Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa.
2014,
Pubmed Schüle,
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity.
2006,
Pubmed Schüle,
Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients.
2016,
Pubmed Scorilas,
Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.
2002,
Pubmed Sega,
De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy.
2019,
Pubmed
,
Xenbase Słabicki,
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia.
2010,
Pubmed Solowska,
Hereditary spastic paraplegia SPG4: what is known and not known about the disease.
2015,
Pubmed Srinivasan,
Alpha adaptins show isoform-specific association with neurofibrillary tangles in Alzheimer's disease.
2022,
Pubmed Stevanin,
Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration.
2008,
Pubmed Torii,
NuMA1 promotes axon initial segment assembly through inhibition of endocytosis.
2020,
Pubmed Traub,
Crystal structure of the alpha appendage of AP-2 reveals a recruitment platform for clathrin-coat assembly.
1999,
Pubmed Verkerk,
Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy.
2009,
Pubmed Wen,
Thyroid Hormone Receptor α Controls Developmental Timing and Regulates the Rate and Coordination of Tissue-Specific Metamorphosis in Xenopus tropicalis.
2017,
Pubmed
,
Xenbase Wigge,
Inhibition of receptor-mediated endocytosis by the amphiphysin SH3 domain.
1997,
Pubmed Yalcouyé,
Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.
2022,
Pubmed
